| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | AKORN INC | 815 | 1,918,000 | 0.10% | Call | |
| 102 | REDHILL BIOPHARMA LTD | 156,523 | 1,917,000 | 0.10% | ||
| 103 | MEDICINES CO | 1,500,000 | 1,913,000 | 0.10% | PRN | |
| 104 | INVIVO THERAPEUTICS HLDGS CO | 2,725 | 1,902,000 | 0.10% | Call | |
| 105 | VERTEX PHARMACEUTICALS INC | 23,320 | 1,854,000 | 0.09% | ||
| 106 | SERES THERAPEUTICS INC | 69,287 | 1,840,000 | 0.09% | ||
| 107 | ACURA PHARMACEUTICALS INC | 648,884 | 1,836,000 | 0.09% | ||
| 108 | CEMPRA INC | 1,044 | 1,829,000 | 0.09% | Call | |
| 109 | SANGAMO THERAPEUTICS INC | 3,005 | 1,818,000 | 0.09% | Call | |
| 110 | BIODELIVERY SCIENCES INTL IN | 555,969 | 1,796,000 | 0.09% | ||
| 111 | ADURO BIOTECH INC | 1,401 | 1,795,000 | 0.09% | Call | |
| 112 | GW PHARMACEUTICALS PLC | 24,603 | 1,775,000 | 0.09% | ||
| 113 | CARDICA INC | 498,600 | 1,775,000 | 0.09% | ||
| 114 | ACHILLION PHARMACEUTICALS INC | 2,298 | 1,774,000 | 0.09% | Call | |
| 115 | CEMPRA INC | 100,000 | 1,752,000 | 0.09% | ||
| 116 | FOAMIX PHARMACEUTICALS LTD | 260,400 | 1,698,000 | 0.08% | ||
| 117 | BRISTOL MYERS SQUIBB CO | 264 | 1,686,000 | 0.08% | Call | |
| 118 | RELYPSA INC | 122,905 | 1,665,000 | 0.08% | ||
| 119 | PROTHENA CORP PLC | 40,000 | 1,646,000 | 0.08% | ||
| 120 | AETERNA ZENTARIS INC | 492,485 | 1,635,000 | 0.08% | ||
| 121 | KITE PHARMA INC | 605 | 1,632,000 | 0.08% | Call | |
| 122 | ALLIQUA BIOMEDICAL INC | 1,967,208 | 1,613,000 | 0.08% | ||
| 123 | GALECTIN THERAPEUTICS INC COM | 1,072,765 | 1,534,000 | 0.08% | ||
| 124 | LIPOCINE INC NEW | 151,086 | 1,534,000 | 0.08% | ||
| 125 | HORIZON PHARMA PLC | 908 | 1,505,000 | 0.08% | Call | |
| 126 | Progenics Pharmaceuticals Inc | 345,197 | 1,505,000 | 0.08% | ||
| 127 | COLLEGIUM PHARMACEUTICAL INC COM | 82,100 | 1,490,000 | 0.07% | ||
| 128 | DEPOMED INC | 106,057 | 1,477,000 | 0.07% | ||
| 129 | NEUROCRINE BIOSCIE COM USD0.001 | 365 | 1,444,000 | 0.07% | Call | |
| 130 | T2 BIOSYSTEMS INCORPORATED | 145,000 | 1,430,000 | 0.07% | ||
| 131 | MYLAN N V | 304 | 1,409,000 | 0.07% | Call | |
| 132 | ENDO INTL PLC | 50,000 | 1,408,000 | 0.07% | ||
| 133 | AMARIN CORP PLC | 870,792 | 1,332,000 | 0.07% | ||
| 134 | AMARIN CORP PLC | 8,684 | 1,329,000 | 0.07% | Call | |
| 135 | ACCELERON PHARMA INC | 50,000 | 1,320,000 | 0.07% | ||
| 136 | BRAINSTORM CELL THERAPEUTICS | 493,191 | 1,317,000 | 0.07% | ||
| 137 | FORWARD PHARMA A/S | 76,785 | 1,305,000 | 0.07% | ||
| 138 | ACADIA PHARMACEUTICALS INC COM | 46,258 | 1,293,000 | 0.06% | ||
| 139 | ImmunoCellular Therapeutics Lt | 4,411,371 | 1,279,000 | 0.06% | ||
| 140 | AKORN INCORPORATED | 53,729 | 1,264,000 | 0.06% | ||
| 141 | NEUROMETRIX INC | 3,130,468 | 1,252,000 | 0.06% | ||
| 142 | MIRATI THERAPEUTICS INC COM | 56,400 | 1,207,000 | 0.06% | ||
| 143 | CEMPRA INC | 672 | 1,177,000 | 0.06% | Put | |
| 144 | MEDGENICS EQUITY WARRANTS EXP 13 FEB 2018 | 1,564,370 | 1,173,000 | 0.06% | ||
| 145 | OCERA THERAPEUTICS INC | 399,035 | 1,173,000 | 0.06% | ||
| 146 | OPKO HEALTH INC | 112,011 | 1,164,000 | 0.06% | ||
| 147 | DYNAVAX TECHNOLOGIES CORP | 605 | 1,164,000 | 0.06% | Put | |
| 148 | RICEBRAN TECHNOLOGIES | 1,017,458 | 1,140,000 | 0.06% | ||
| 149 | OPKO HEALTH INC | 1,095 | 1,138,000 | 0.06% | Put | |
| 150 | FLUIDIGM CORP DEL COM | 139,506 | 1,126,000 | 0.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-101848, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
